People enrolled in a pharmacist-led telemonitoring program to control high blood pressure were about half as likely to have a heart attack or stroke compared to those who received routine primary care, according to new research published today in Hypertension, an American Heart Association journal.

As countries around the world race to develop a vaccine for SARS-CoV-2, the virus responsible for COVID-19, researchers are working to understand exactly how it causes the myriad of symptoms that seem to linger long after active viral infection. 

Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. 

New biomaterials developed at the University of Bayreuth eliminate risk of infection and facilitate healing processes.

An international study reveals how future climate change could affect malaria transmission in Africa over the next century.

Researchers at the University of Alberta are preparing to launch clinical trials of a drug used to cure a deadly disease caused by a coronavirus in cats that they expect will also be effective as a treatment for humans against COVID-19.

N95 respirators, which are widely worn by health care workers treating patients with COVID-19 and are designed to be used only once, can be decontaminated effectively and used up to three times, according to research by UCLA scientists and colleagues.

Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.

HRRR-Smoke is particularly valuable for notifying those downwind of a fire about what’s headed their way.

The supervisor of Texas A&M's urban resilience lab says that Hurricane Laura and ongoing wildfires are compounding the risks of the virus.